ReachMD

Episodes 16-30 of 39

• • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Lisa A. Coco, CRNP

    Peer

  • 

    

    Deborah Hinnen, NP

    Peer

  • 

    

    Davida F. Kruger, CNP

    Peer

  2

  

  RestartResume

  Practical CDE Insights Toward the 2020 ADA Standards of Medical Care in Diabetes for Glycemic Control

  Practical CDE Insights Toward the 2020 ADA Standards of Medical Care in Diabetes for Glycemic Control

• • 

    

    Matt Birnholz, MD

    Peer

  • 

    

    Gary Cohen, MD

    Peer

  7

  

  RestartResume

  Part 1: Are You Ready for Biosimilars? What the Oncology Team Should Know

  Part 1: Are You Ready for Biosimilars? What the Oncology Team Should Know

• • 

    

    Matt Birnholz, MD

    Peer

  • 

    

    Gary Cohen, MD

    Peer

  4

  

  RestartResume

  Part 2: Are You Ready for Biosimilars? What the Oncology Team Should Know

  Part 2: Are You Ready for Biosimilars? What the Oncology Team Should Know
• 3

  

  RestartResume

  Potential Mechanisms of Chronic Cough

  Potential Mechanisms of Chronic Cough
• 0

  

  RestartResume

  The Power of Comprehensive Care & Music Therapy in MS

  The Power of Comprehensive Care & Music Therapy in MS

• • 

    

    John J. Russell, MD

    Peer

  • 

    

    Robin K. Dore, MD

    Peer

  • 

    

    Wendy Simmons, PA-C

    Peer

  6

  

  RestartResume

  Navigating the Prior Authorization Process: Expert Perspective for a Postmenopausal Osteoporosis Therapy

  Navigating the Prior Authorization Process: Expert Perspective for a Postmenopausal Osteoporosis Therapy

• • 

    

    Vincent Hsu, MD

    Peer

  2

  

  RestartResume

  How to Talk About Pneumococcal Disease With Your Adult Patients at Increased Risk

  How to Talk About Pneumococcal Disease With Your Adult Patients at Increased Risk

• • 

    

    Vincent Hsu, MD

    Peer

  1

  

  RestartResume

  CDC Recommendations for Pneumococcal Disease in Adults Under Age 65 With Certain Chronic Conditions

  CDC Recommendations for Pneumococcal Disease in Adults Under Age 65 With Certain Chronic Conditions

• • 

    

    Javeed Siddiqui, MD, MPH

    Peer

  1

  

  RestartResume

  Understanding 2019 CDC Recommendations for Pneumococcal Disease in Adults Ages 65+

  Understanding 2019 CDC Recommendations for Pneumococcal Disease in Adults Ages 65+

• • 

    

    Paul Doghramji, MD

    Peer

  2

  

  RestartResume

  Challenges in Identifying, Assessing, & Monitoring Excessive Daytime Sleepiness in Obstructive Sleep Apnea

  Challenges in Identifying, Assessing, & Monitoring Excessive Daytime Sleepiness in Obstructive Sleep Apnea

• • 

    

    Richard K. Bogan, MD

    Peer

  1

  

  RestartResume

  Pathophysiology of Obstructive Sleep Apnea & Its Role in Excessive Daytime Sleepiness

  Pathophysiology of Obstructive Sleep Apnea & Its Role in Excessive Daytime Sleepiness

• • 

    

    Richard K. Bogan, MD

    Peer

  8

  

  RestartResume

  Prevalence of Excessive Daytime Sleepiness in Obstructive Sleep Apnea

  Prevalence of Excessive Daytime Sleepiness in Obstructive Sleep Apnea

• • 

    

    Matt Birnholz, MD

    Peer

  • 

    

    Jessica Ailani, MD

    Peer

  0

  

  RestartResume

  Adverse Event Detection & Reporting: What Healthcare Providers Need to Know

  Adverse Event Detection & Reporting: What Healthcare Providers Need to Know

• • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Hilary Baldwin, MD

    Peer

  0

  

  RestartResume

  Achieving Clearer Skin with a Rosacea Treatment

  Achieving Clearer Skin with a Rosacea Treatment

• • 

    

    Hilary Baldwin, MD

    Peer

  2

  

  RestartResume

  Rosacea’s Impact Is more than Skin Deep…Shifting Treatment Paradigms

  Rosacea’s Impact Is more than Skin Deep…Shifting Treatment Paradigms

• Prev
• 1
• 2
• 3
• Next